{"id":"https://openalex.org/W2048658173","doi":"https://doi.org/10.1080/10401230500464588","title":"A Regional Comparison of Developing Diabetes among VA Patients Exposed to Typical and Atypical Antipsychotics Relative to Corticosteroids and Proton Pump Inhibitors","display_name":"A Regional Comparison of Developing Diabetes among VA Patients Exposed to Typical and Atypical Antipsychotics Relative to Corticosteroids and Proton Pump Inhibitors","publication_year":2006,"publication_date":"2006-01-01","ids":{"openalex":"https://openalex.org/W2048658173","doi":"https://doi.org/10.1080/10401230500464588","mag":"2048658173","pmid":"https://pubmed.ncbi.nlm.nih.gov/16517447"},"language":"en","primary_location":{"id":"doi:10.1080/10401230500464588","doi":"https://doi.org/10.1080/10401230500464588","is_oa":false,"landing_page_url":"https://doi.org/10.1080/10401230500464588","pdf_url":null,"source":{"id":"https://openalex.org/S132142010","display_name":"Annals of Clinical Psychiatry","issn_l":"1040-1237","issn":["1040-1237","1547-3325","1573-3238"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","norway-1","poland-70","russia-white-list-2"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Clinical Psychiatry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022600380","display_name":"Mitchell J. Barnett","orcid":"https://orcid.org/0000-0002-9645-9865","observed_orcids":["https://orcid.org/0000-0002-9645-9865"]},"institutions":[{"id":"https://openalex.org/I4210132647","display_name":"Iowa City VA Health Care System","ror":"https://ror.org/04hgm3062","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210132647","https://openalex.org/I4210159720"]},{"id":"https://openalex.org/I4210135841","display_name":"Iowa City VA Medical Center","ror":"https://ror.org/03r9k1585","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210132647","https://openalex.org/I4210135841","https://openalex.org/I4210159720"]},{"id":"https://openalex.org/I86519309","display_name":"The University of Texas at Austin","ror":"https://ror.org/00hj54h04","country_code":"US","type":"education","lineage":["https://openalex.org/I86519309"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mitchell Barnett","raw_affiliation_strings":["University of Texas College of Pharmacy, Austin, TX, USA. BarnettM@Mail.Medicine.Uiowa.Edu","Center for Research in the Implementation of Innovative Strategies in Practice (CRIISP) Veterans Administration Hospital, Iowa City, IA, USA; Touro College of Pharmacy, Vallejo, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas College of Pharmacy, Austin, TX, USA. BarnettM@Mail.Medicine.Uiowa.Edu","institution_ids":["https://openalex.org/I86519309"]},{"raw_affiliation_string":"Center for Research in the Implementation of Innovative Strategies in Practice (CRIISP) Veterans Administration Hospital, Iowa City, IA, USA; Touro College of Pharmacy, Vallejo, CA, USA","institution_ids":["https://openalex.org/I4210132647","https://openalex.org/I4210135841"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035678337","display_name":"Tami R. Argo","orcid":"https://orcid.org/0000-0002-8016-7040","observed_orcids":["https://orcid.org/0000-0002-8016-7040"]},"institutions":[{"id":"https://openalex.org/I86519309","display_name":"The University of Texas at Austin","ror":"https://ror.org/00hj54h04","country_code":"US","type":"education","lineage":["https://openalex.org/I86519309"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tami Argo","raw_affiliation_strings":["University of Texas College of Pharmacy, Austin, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas College of Pharmacy, Austin, TX, USA","institution_ids":["https://openalex.org/I86519309"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010019881","display_name":"BRUCE K. ALEXANDER","orcid":"https://orcid.org/0000-0002-4090-2274","observed_orcids":["https://orcid.org/0000-0002-4090-2274"]},"institutions":[{"id":"https://openalex.org/I1322918889","display_name":"United States Department of Veterans Affairs","ror":"https://ror.org/05rsv9s98","country_code":"US","type":"government","lineage":["https://openalex.org/I1322918889"]},{"id":"https://openalex.org/I4210135841","display_name":"Iowa City VA Medical Center","ror":"https://ror.org/03r9k1585","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210132647","https://openalex.org/I4210135841","https://openalex.org/I4210159720"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bruce Alexander","raw_affiliation_strings":["Veterans Administration Hospital, Iowa City, IA (USA)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Veterans Administration Hospital, Iowa City, IA (USA)","institution_ids":["https://openalex.org/I1322918889","https://openalex.org/I4210135841"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112156725","display_name":"Paul J. Perry","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I126307644","display_name":"University of Iowa","ror":"https://ror.org/036jqmy94","country_code":"US","type":"education","lineage":["https://openalex.org/I126307644"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul Perry","raw_affiliation_strings":["Touro College of Pharmacy, Vallejo, CA, USA; University of Iowa College of Medicine, Iowa City, IA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Touro College of Pharmacy, Vallejo, CA, USA; University of Iowa College of Medicine, Iowa City, IA, USA","institution_ids":["https://openalex.org/I126307644"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":0.3647,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.63635462,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"18","issue":"1","first_page":"1","last_page":"7"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9336000084877014,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9336000084877014,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.010099999606609344,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.004100000020116568,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/new-onset-diabetes","display_name":"new-onset diabetes","score":0.9089999794960022},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.9470000267028809},{"id":"https://openalex.org/keywords/typical-antipsychotics","display_name":"typical antipsychotics","score":0.9919999837875366},{"id":"https://openalex.org/keywords/corticosteroids","display_name":"corticosteroids","score":0.9670000076293945},{"id":"https://openalex.org/keywords/proton-pump-inhibitors","display_name":"proton pump inhibitors","score":0.9990000128746033},{"id":"https://openalex.org/keywords/veterans","display_name":"veterans","score":0.6790000200271606},{"id":"https://openalex.org/keywords/antipsychotic-induced-metabolic-effects","display_name":"antipsychotic-induced metabolic effects","score":0.5920000076293945},{"id":"https://openalex.org/keywords/blood-glucose-monitoring","display_name":"blood glucose monitoring","score":0.6299999952316284},{"id":"https://openalex.org/keywords/regional-comparison","display_name":"regional comparison","score":0.527999997138977}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7967216968536377},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.710746705532074},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.6585553884506226},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5797206163406372},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5618215203285217},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.5274232625961304},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.4512837529182434},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.4233427941799164},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.35380488634109497},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.34302830696105957},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.2461501955986023},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.09327965974807739},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077152","descriptor_name":"Olanzapine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000305","descriptor_name":"Adrenal Cortex Hormones","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000305","descriptor_name":"Adrenal Cortex Hormones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000553","descriptor_name":"Ambulatory Care","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D000897","descriptor_name":"Anti-Ulcer Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000897","descriptor_name":"Anti-Ulcer Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010343","descriptor_name":"Patient Admission","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D012044","descriptor_name":"Regression Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014728","descriptor_name":"Veterans","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true},{"descriptor_ui":"D015430","descriptor_name":"Weight Gain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D054328","descriptor_name":"Proton Pump Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1080/10401230500464588","doi":"https://doi.org/10.1080/10401230500464588","is_oa":false,"landing_page_url":"https://doi.org/10.1080/10401230500464588","pdf_url":null,"source":{"id":"https://openalex.org/S132142010","display_name":"Annals of Clinical Psychiatry","issn_l":"1040-1237","issn":["1040-1237","1547-3325","1573-3238"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","norway-1","poland-70","russia-white-list-2"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Clinical Psychiatry","raw_type":"journal-article"},{"id":"pmid:16517447","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16517447","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists","raw_type":"Comparative Study"},{"id":"mag:2187956416","doi":null,"is_oa":false,"landing_page_url":"http://psychrights.org/research/digest/nlps/seroquel/seroquelmedicalstudies/gen. cause resp. ex 47.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320309610","display_name":"Health Services Research and Development","ror":"https://ror.org/05rsv9s98"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W1982223371","https://openalex.org/W1982916730","https://openalex.org/W1987632018","https://openalex.org/W1993073314","https://openalex.org/W1995963413","https://openalex.org/W2016019346","https://openalex.org/W2025380847","https://openalex.org/W2032748018","https://openalex.org/W2033834604","https://openalex.org/W2035259752","https://openalex.org/W2058296375","https://openalex.org/W2063148733","https://openalex.org/W2071430880","https://openalex.org/W2076304958","https://openalex.org/W2079595233","https://openalex.org/W2083758093","https://openalex.org/W2088025346","https://openalex.org/W2090149171","https://openalex.org/W2107274852","https://openalex.org/W2111105929","https://openalex.org/W2114432661","https://openalex.org/W2130708072","https://openalex.org/W2131537784","https://openalex.org/W2135491929","https://openalex.org/W2150145013","https://openalex.org/W2160802754","https://openalex.org/W2322979841","https://openalex.org/W2325984923","https://openalex.org/W2333227733","https://openalex.org/W2430324231"],"related_works":["https://openalex.org/W2187956416","https://openalex.org/W2160525698","https://openalex.org/W2596775156","https://openalex.org/W2089272346","https://openalex.org/W2130708072","https://openalex.org/W2146077810","https://openalex.org/W2040738795","https://openalex.org/W2139705794","https://openalex.org/W2413053991","https://openalex.org/W1982223371"],"abstract_inverted_index":{"BACKGROUND:":[0],"Metabolic":[1],"changes,":[2],"including":[3,178],"weight":[4],"gain":[5],"and":[6,18,30,45,184,205,222],"onset":[7],"of":[8,24,34,120,139,163,171,202,216,242,250,259],"diabetes,":[9],"have":[10],"been":[11],"associated":[12,231],"with":[13,232,256],"both":[14,203],"systemic":[15],"corticosteroid":[16,86],"use":[17,258],"atypical":[19,98,206,233],"antipsychotic":[20],"drugs.":[21],"The":[22,228],"purpose":[23],"this":[25],"study":[26,59],"was":[27,235],"to":[28,131,174,208,237,246],"quantify":[29],"compare":[31],"the":[32,124,140,149,199],"risk":[33,162,215,230],"new-onset":[35],"diabetes":[36,121,147,165,218],"mellitus":[37],"in":[38,77,103,123,169,198],"a":[39,54,85,88,93,117,143,159,191],"Veterans":[40,66],"Affairs":[41],"population":[42,141],"receiving":[43,101],"antipsychotics":[44,207,234],"corticosteroids,":[46],"using":[47,154],"persons":[48],"taking":[49],"proton":[50,89],"pump":[51,90],"inhibitors":[52],"as":[53,188,190],"control":[55],"group.":[56],"METHODS:":[57],"This":[58],"included":[60,197],"data":[61],"from":[62,262],"subjects":[63],"treated":[64],"within":[65],"Integrated":[67],"Service":[68],"Network":[69],"23":[70],"who":[71],"had":[72,116,142],"received":[73],"an":[74,97,211,260],"outpatient":[75],"prescription":[76,134],"fiscal":[78],"years":[79],"(FY)":[80],"1999":[81],"or":[82,96,129],"2000":[83],"for":[84,146,193],"(CS),":[87],"inhibitor":[91],"(PPI),":[92],"typical":[94,204],"antipsychotic,":[95],"antipsychotic.":[99],"Patients":[100],"prescriptions":[102],"more":[104],"than":[105,240],"one":[106],"class":[107],"were":[108,112,195],"not":[109],"excluded.":[110],"Subjects":[111],"excluded":[113],"if":[114],"they":[115],"documented":[118],"diagnosis":[119,145],"either":[122,263],"previous":[125],"FY":[126],"year":[127],"(1998)":[128],"prior":[130],"their":[132],"index":[133],"date.":[135],"RESULTS:":[136],"Thirteen":[137],"percent":[138],"new":[144],"during":[148],"two-year":[150],"study.":[151],"Cox-regression":[152],"analysis":[153],"time":[155],"dependent":[156],"covariates":[157],"determined":[158],"significantly":[160],"higher":[161],"developing":[164,217],"(RR":[166,219],"=":[167,220,224],"1.21)":[168],"users":[170],"CS":[172],"relative":[173],"PPIs.":[175],"Demographic":[176],"variables":[177],"age,":[179],"race,":[180],"gender,":[181],"marital":[182],"status,":[183],"VA":[185],"financial":[186],"classification":[187],"well":[189],"marker":[192],"schizophrenia,":[194],"also":[196],"model.":[200],"Comparison":[201],"PPIs":[209],"found":[210,236],"increased":[212],"but":[213],"nonsignificant":[214],"1.18":[221],"RR":[223],"1.19":[225],"respectively).":[226],"CONCLUSIONS:":[227],"diabetogenic":[229],"be":[238,254],"less":[239],"that":[241],"corticosteroids":[243],"when":[244],"compared":[245],"controls.":[247],"Periodic":[248],"monitoring":[249],"blood":[251],"glucose":[252],"should":[253],"considered":[255],"chronic":[257],"agent":[261],"class.":[264]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}